Home›Search›European Journal of Oncology Pharmacy

European Journal of Oncology Pharmacy

Pharma Publishing and Media Europe · Belgium · Est. 2008

ISSN1783-3914

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.211

H-Indexi

SNIPi

0.525

Total Worksi

Total Citationsi

223

2yr Mean Citednessi

0.78

Open Impact Factor alternative

Aims & Scope

Subject areas: Oncology; Pharmacology.

General Information

Country / RegionBelgium

Primary Language—

1st Year Published2008

Annual Volume~ 6 articles / year

StatusActive (last: 2025)

Total Publications71

Publisher OrgLippincott Williams & Wilkins

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/11 · 45%

✅

Do you know the journal / publisher?

Pharma Publishing and Media Europe

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1783-3914

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ4

PharmacologyQ4

Subject Classification

Scopus Categories

PharmacologyOncology

Research Topics (OpenAlex)

Safe Handling of Antineoplastic DrugsPharmaceutical studies and practicesPharmaceutical Practices and Patient OutcomesCancer Treatment and PharmacologyHER2/EGFR in Cancer ResearchMedication Adherence and ComplianceBreast Cancer Treatment StudiesMonoclonal and Polyclonal Antibodies ResearchCOVID-19 and healthcare impactsCancer therapeutics and mechanisms

Frequently asked questions about European Journal of Oncology Pharmacy

Is European Journal of Oncology Pharmacy a predatory journal?

PubScope has no integrity flags on record for European Journal of Oncology Pharmacy: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of European Journal of Oncology Pharmacy?

European Journal of Oncology Pharmacy is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.211.

Is European Journal of Oncology Pharmacy indexed in Scopus and Web of Science?

European Journal of Oncology Pharmacy is indexed in Scopus.

What is the aims and scope of European Journal of Oncology Pharmacy?